Ji YX - Search Results

1

Sorafenib in liver function impaired advanced hepatocellular carcinoma.

Ji YX, Zhang ZF, Lan KT, Nie KK, Geng CX, Liu SC, Zhang L, Zhuang XJ, Zou X, Sun L, Zhang ZC. Ji YX, et al. Chin Med Sci J. 2014 Mar;29(1):7-14. doi: 10.1016/s1001-9294(14)60017-1. Chin Med Sci J. 2014. PMID: 24698672 Clinical Trial.

2

Severe acute interstitial lung disease induced by crizotinib therapy in a patient with c-Met amplification non-small cell lung cancer.

Ji Y, Zhang Z, Nie K, Lan K, Geng C, Liu S, Zhang L, Zhang Z, Sun L, Zou X. Ji Y, et al. Chin Med J (Engl). 2014;127(8):1600. Chin Med J (Engl). 2014. PMID: 24762619 No abstract available.

3

AZD9291-induced Acute Interstitial Lung Disease.

Nie KK, Zou X, Geng CX, Zhang L, Liu SC, Zhang CL, Ji YX. Nie KK, et al. Among authors: ji yx. Chin Med J (Engl). 2016 Jun 20;129(12):1507-8. doi: 10.4103/0366-6999.183426. Chin Med J (Engl). 2016. PMID: 27270553 Free PMC article. No abstract available.

4

Clinical Observation of Bevacizumab Combined with S-1 in the Treatment of Pretreated Advanced Esophageal Carcinoma.

Nie K, Geng C, Zhang L, Liu S, Zhang Z, Wang R, Zou X, Ji Y. Nie K, et al. Chin Med Sci J. 2016 Nov 20;31(4):221-7. doi: 10.1016/s1001-9294(17)30004-4. Chin Med Sci J. 2016. PMID: 28065218

5

Mutational Profiling of Non-Small-Cell Lung Cancer Resistant to Osimertinib Using Next-Generation Sequencing in Chinese Patients.

Nie K, Jiang H, Zhang C, Geng C, Xu X, Zhang L, Zhang H, Zhang Z, Lan K, Ji Y. Nie K, et al. Biomed Res Int. 2018 Mar 11;2018:9010353. doi: 10.1155/2018/9010353. eCollection 2018. Biomed Res Int. 2018. PMID: 29713646 Free PMC article. Clinical Trial.

6

Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer.

Nie K, Zhang Z, Zhang C, Geng C, Zhang L, Xu X, Liu S, Wang S, Zhuang X, Lan K, Ji Y. Nie K, et al. Lung Cancer. 2018 Jul;121:5-11. doi: 10.1016/j.lungcan.2018.04.012. Epub 2018 Apr 17. Lung Cancer. 2018. PMID: 29858027 Clinical Trial.

7

Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement: a case report.

Zhang L, Li Y, Zhang S, Gao C, Nie K, Ji Y. Zhang L, et al. Cancer Biol Med. 2018 May;15(2):178-181. doi: 10.20892/j.issn.2095-3941.2018.0003. Cancer Biol Med. 2018. PMID: 29951342 Free PMC article.

8

Successful Treatment of Erlotinib on Metastatic Adenoid Cystic Carcinoma of the Lacrimal Gland.

Nie KK, Xu J, Gao C, Zhang ZF, Lan KT, Ji YX. Nie KK, et al. Among authors: ji yx. Chin Med J (Engl). 2018 Jul 20;131(14):1746-1747. doi: 10.4103/0366-6999.235887. Chin Med J (Engl). 2018. PMID: 29998897 Free PMC article. No abstract available.

9

Treatment of Skin Reaction Induced by Nivolumab Combined with Radiotherapy in Non-small Cell Lung Cancer: A Case Report.

Zhao ZM, Liu SC, Xu XJ, Zhang ZF, Nie KK, Ji YX. Zhao ZM, et al. Among authors: ji yx. Chin Med Sci J. 2018 Sep 20;33(3):183-187. doi: 10.24920/31805. Chin Med Sci J. 2018. PMID: 30266109

10

Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer.

Zhu C, You YH, Nie KK, Ji YX. Zhu C, et al. Among authors: ji yx. Chin Med J (Engl). 2019 May 5;132(9):1115-1116. doi: 10.1097/CM9.0000000000000196. Chin Med J (Engl). 2019. PMID: 31033571 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters